Abbott has taken a step forward in the development of a new addition to its structural heart portfolio, completing the first ...

Meril Life Sciences, a leading global med-tech company specializing in cardiovascular and structural heart solutions, marked ...

The Myval THV series, known for its innovative contributions to transcatheter aortic valve replacement (TAVR) procedures, ...

McKay-Dee Hospital has used a relatively new heart procedure that has saved 500-plus lives. Patients would have had to go to ...

ABT recently announced the first patient procedures with its investigational transcatheter aortic valve implantation (TAVI) ...

An octogenarian has successfully undergone a transcatheter aortic valve replacement (TAVR) procedure at General Hospital, Ernakulam.

The randomized trial will use Tempus’ platform to find patients who are eligible for interventions such as TAVR but do not ...

Boston Scientific (NYSE:BSX) shared data highlighting the safety and efficacy of its Acurate Prime XL aortic valve system.

Abbott today announced the first patient procedures with its investigational transcatheter aortic valve implantation (TAVI) ...

Medtronic plc and Tempus AI Inc. launched the ALERT study to better understand and address the racial, ethnic, gender and ...

Intermountain McKay-Dee hospital in Ogden achieved a major milestone in the treatment of a deadly and common aortic heart ...

Meril Life Sciences, a leading global med-tech company specializing in cardiovascular and structural heart solutions, marked a significant milestone with the launch of its Myval Octapro Transcatheter ...